Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: MannKind Corporation to Present at The 24th Annual Piper Jaffray Healthcare Conf

Overall, good Q & A session. We certainly need to be realistic with timelines. When they say resubmission in Q3, count on late September at the earliest. I am counting on stunning trial results, given the explanation of their design. I hope this is followed shortly by some firm partnership offers - companies won't want to miss the boat once they see the potential right in front of them. Then maybe we see some escalation in dealmaking!

Wells

Share
New Message
Please login to post a reply